Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 4, pp. 200-214
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels
José de León, Georgios Schoretsanitis, Robert L. Smith, et al.
Pharmacopsychiatry (2021) Vol. 55, Iss. 02, pp. 73-86
Open Access | Times Cited: 178
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
Chiara Gastaldon, Emanuel Raschi, John M. Kane, et al.
Psychotherapy and Psychosomatics (2020) Vol. 90, Iss. 1, pp. 41-48
Closed Access | Times Cited: 93
Impact of smoking behavior on clozapine blood levels – a systematic review and meta‐analysis
Elias Wagner, Laura McMahon, Peter Falkai, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 142, Iss. 6, pp. 456-466
Open Access | Times Cited: 71
Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, et al.
Pharmacology & Therapeutics (2022) Vol. 236, pp. 108236-108236
Open Access | Times Cited: 48
Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing
José de León
Psychiatry Investigation (2023) Vol. 20, Iss. 3, pp. 183-195
Open Access | Times Cited: 22
Schizophrenia during the COVID-19 pandemic
Sergio Barlati, Gabriele Nibbio, Antonio Vita
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 3, pp. 203-210
Open Access | Times Cited: 55
Clozapine: Why Is It So Uniquely Effective in the Treatment of a Range of Neuropsychiatric Disorders?
Dara Gammon, Catherine Cheng, Anna Volkovinskaia, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1030-1030
Open Access | Times Cited: 51
An update on the complex relationship between clozapine and pneumonia
Georgios Schoretsanitis, Can‐Jun Ruan, Christopher Rohde, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 145-149
Open Access | Times Cited: 42
Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries
Carlos De las Cuevas, Emílio J. Sanz, Can‐Jun Ruan, et al.
Revista de Psiquiatría y Salud Mental (2021) Vol. 15, Iss. 4, pp. 238-250
Closed Access | Times Cited: 42
Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
Μαρία Σκώκου, Eleni A. Karavia, Zoi Drakou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 817-817
Open Access | Times Cited: 31
Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase
Carlos De las Cuevas, Emílio J. Sanz, Christopher Rohde, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 1, pp. 65-78
Closed Access | Times Cited: 30
The Modernization of Clozapine
Jonathan G. Leung, José de León, Mark A. Frye, et al.
Journal of Clinical Psychopharmacology (2022) Vol. 42, Iss. 6, pp. 565-580
Closed Access | Times Cited: 30
An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
General Psychiatry (2022) Vol. 35, Iss. 3, pp. e100773-e100773
Open Access | Times Cited: 29
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition
Georgios Schoretsanitis, A. Elif Anıl Yağcıoğlu, Can‐Jun Ruan, et al.
Schizophrenia Research (2023) Vol. 268, pp. 302-307
Closed Access | Times Cited: 16
Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)
Carlos De las Cuevas, Emílio J. Sanz, José de León
Schizophrenia Research (2023)
Open Access | Times Cited: 16
Clozapine resistant schizophrenia: Newer avenues of management
Subho Chakrabarti
World Journal of Psychiatry (2021) Vol. 11, Iss. 8, pp. 429-448
Open Access | Times Cited: 35
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases
Renato de Filippis, John M. Kane, Nazar Kuzo, et al.
European Neuropsychopharmacology (2022) Vol. 60, pp. 25-37
Open Access | Times Cited: 23
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
Can‐Jun Ruan, I. Cánovas Olmos, Carina Ricciardi, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 15
The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis
Samantha Christine Sernoskie, Alison Jee, Jack Uetrecht
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1243-1243
Open Access | Times Cited: 14
Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research
José de León
Journal of Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 4
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study
Juulia Partanen, Paavo Häppölä, Anders Kämpe, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 4
The effects of clinical and pharmacological factors on the ratio of clozapine to norclozapine in psychiatric patients
Anna Mach, Anna Wnorowska, Marcin Siwek, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes
Nazanin Vaziri, Timothy E. Shutt, Wasi Karim, et al.
Molecular Psychiatry (2025)
Closed Access
Clozapine pharmacovigilance in Croatia: underreporting of specific adverse drug reactions and excellent reporting of suicide attempts
José de León, Marina Šagud, Emílio J. Sanz, et al.
Psychiatry Research (2025), pp. 116408-116408
Closed Access
A New Era of Muscarinic Acetylcholine Receptor Modulators in Neurological Diseases, Cancer and Drug Abuse
Helena Tsimpili, Grigoris Zoidis
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 369-369
Open Access
Page 1 - Next Page

Scroll to top